Retracted: MicroRNA‐217 relieved neuropathic pain through targeting toll‐like receptor 5 expression

Abstract Neuropathic pain is the most common chronic pain that is caused by nerve injury or disease that influences the nervous system. Increasing evidence suggested that microRNAs (miRNAs) play a crucial role in neuropathic pain and neuroinflammation development. However, the functional role of miR‐217 in the development of neuropathic pain remains unknown. In this study, we used rats to establish a neuropathic pain model and showed that the miR‐217 expression level was upregulated in the spinal dorsal horn of bilateral sciatic nerve chronic constriction injury (bCCI). However, the expression of miR‐217 was not changed in the anterior cingulated cortex (ACC), hippocampus, and dorsal root ganglion (DRG) of bCCI rats. Ectopic expression of miR‐217 attenuated neuropathic pain and suppressed neuroinflammation expression in vivo. We identified toll‐like receptor 5 (TLR5) as a direct target gene of miR‐217 in the PC12 cell. In addition, we demonstrated that the expression level of TLR5 was upregulated in bCCI rats. Moreover, restoration of TLR5 rescued the inhibitory roles induced by miR‐217 overexpression on neuropathic pain and neuroinflammation development. These data suggested that miR‐217 played a pivotal role in the development of neuropathic pain partly through regulating TLR5 expression.